Second what @werdplaya58 stated above. You make baseless assertions. Look at the facts as they are set out in the most recent annual report. Despite COVID, despite the declining birthrates etc A2Milk is continuing to grow its market share and is using the market regulation to its advantage.
The trend in the China IF market is consolidation, weak hands are dropping out and the strong are gaining their share. This is why A2M can continue growing in a declining market. As A2M roll out new products ie lower priced Gold product, adult products etc, they will continue to grow in the China IF and dairy nutrition market.
Elderly nutrition upside is not yet priced in. It could become a significant growth driver and all the talk about the aging population can continue with a positive spin.
Second what @werdplaya58 stated above. You make baseless...
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.71 |
Change
-0.060(1.04%) |
Mkt cap ! $4.134B | |||
| Open | High | Low | Value | Volume |
| $5.70 | $5.78 | $5.69 | $6.339M | 1.108M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $5.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.72 | 1701 | 2 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| A2M (ASX) Chart |